Production of plasma proteins for therapeutic use:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Hoboken, N.J.
John Wiley & Sons
c2013
|
| Schlagworte: | |
| Beschreibung: | xii, 496 p. |
| ISBN: | 9781118356784 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044849731 | ||
| 003 | DE-604 | ||
| 005 | 20180305 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180305s2013 |||| o||u| ||||||eng d | ||
| 020 | |a 9781118356784 |c Online |9 978-1-118-35678-4 | ||
| 035 | |a (ZDB-38-ESG)ebr10639275 | ||
| 035 | |a (OCoLC)794306445 | ||
| 035 | |a (DE-599)BVBBV044849731 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.3/9 |2 23 | |
| 084 | |a WW 8800 |0 (DE-625)152144:13423 |2 rvk | ||
| 245 | 1 | 0 | |a Production of plasma proteins for therapeutic use |c edited by Joseph Bertolini, Neil Goss, John Curling |
| 264 | 1 | |a Hoboken, N.J. |b John Wiley & Sons |c c2013 | |
| 300 | |a xii, 496 p. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 505 | 8 | |a Includes bibliographical references and index | |
| 505 | 8 | |a section 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation | |
| 650 | 4 | |a Blood proteins |x Therapeutic use | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Plasmaprotein-Fraktionierung |0 (DE-588)4193446-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Plasmaproteine |0 (DE-588)4127411-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Plasmaproteine |0 (DE-588)4127411-8 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Plasmaprotein-Fraktionierung |0 (DE-588)4193446-5 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Bertolini, Joseph |e Sonstige |4 oth | |
| 700 | 1 | |a Goss, Neil |e Sonstige |4 oth | |
| 700 | 1 | |a Curling, J. M. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-92431-0 |
| 912 | |a ZDB-38-ESG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030244592 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804178365100326912 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV044849731 |
| classification_rvk | WW 8800 |
| collection | ZDB-38-ESG |
| contents | Includes bibliographical references and index section 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation |
| ctrlnum | (ZDB-38-ESG)ebr10639275 (OCoLC)794306445 (DE-599)BVBBV044849731 |
| dewey-full | 615.3/9 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.3/9 |
| dewey-search | 615.3/9 |
| dewey-sort | 3615.3 19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Biologie Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02099nmm a2200481zc 4500</leader><controlfield tag="001">BV044849731</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180305 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180305s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118356784</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-118-35678-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-38-ESG)ebr10639275</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)794306445</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044849731</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.3/9</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WW 8800</subfield><subfield code="0">(DE-625)152144:13423</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Production of plasma proteins for therapeutic use</subfield><subfield code="c">edited by Joseph Bertolini, Neil Goss, John Curling</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">John Wiley & Sons</subfield><subfield code="c">c2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xii, 496 p.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">section 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood proteins</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Plasmaprotein-Fraktionierung</subfield><subfield code="0">(DE-588)4193446-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Plasmaproteine</subfield><subfield code="0">(DE-588)4127411-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Plasmaproteine</subfield><subfield code="0">(DE-588)4127411-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Plasmaprotein-Fraktionierung</subfield><subfield code="0">(DE-588)4193446-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bertolini, Joseph</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goss, Neil</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Curling, J. M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-92431-0</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-38-ESG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030244592</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV044849731 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:02:48Z |
| institution | BVB |
| isbn | 9781118356784 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030244592 |
| oclc_num | 794306445 |
| open_access_boolean | |
| physical | xii, 496 p. |
| psigel | ZDB-38-ESG |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | John Wiley & Sons |
| record_format | marc |
| spelling | Production of plasma proteins for therapeutic use edited by Joseph Bertolini, Neil Goss, John Curling Hoboken, N.J. John Wiley & Sons c2013 xii, 496 p. txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index section 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation Blood proteins Therapeutic use Therapie (DE-588)4059798-2 gnd rswk-swf Plasmaprotein-Fraktionierung (DE-588)4193446-5 gnd rswk-swf Plasmaproteine (DE-588)4127411-8 gnd rswk-swf Plasmaproteine (DE-588)4127411-8 s Therapie (DE-588)4059798-2 s 1\p DE-604 Plasmaprotein-Fraktionierung (DE-588)4193446-5 s 2\p DE-604 Bertolini, Joseph Sonstige oth Goss, Neil Sonstige oth Curling, J. M. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 978-0-470-92431-0 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Production of plasma proteins for therapeutic use Includes bibliographical references and index section 1. Introduction to plasma fractionation -- section 2. Plasma proteins for therapeutic use -- section 3. Pathogen safety of plasma products -- section 4. The pharmaceutical environment applied to plasma fractionation -- section 5. The market for plasma products and the economics of fractionation Blood proteins Therapeutic use Therapie (DE-588)4059798-2 gnd Plasmaprotein-Fraktionierung (DE-588)4193446-5 gnd Plasmaproteine (DE-588)4127411-8 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4193446-5 (DE-588)4127411-8 |
| title | Production of plasma proteins for therapeutic use |
| title_auth | Production of plasma proteins for therapeutic use |
| title_exact_search | Production of plasma proteins for therapeutic use |
| title_full | Production of plasma proteins for therapeutic use edited by Joseph Bertolini, Neil Goss, John Curling |
| title_fullStr | Production of plasma proteins for therapeutic use edited by Joseph Bertolini, Neil Goss, John Curling |
| title_full_unstemmed | Production of plasma proteins for therapeutic use edited by Joseph Bertolini, Neil Goss, John Curling |
| title_short | Production of plasma proteins for therapeutic use |
| title_sort | production of plasma proteins for therapeutic use |
| topic | Blood proteins Therapeutic use Therapie (DE-588)4059798-2 gnd Plasmaprotein-Fraktionierung (DE-588)4193446-5 gnd Plasmaproteine (DE-588)4127411-8 gnd |
| topic_facet | Blood proteins Therapeutic use Therapie Plasmaprotein-Fraktionierung Plasmaproteine |
| work_keys_str_mv | AT bertolinijoseph productionofplasmaproteinsfortherapeuticuse AT gossneil productionofplasmaproteinsfortherapeuticuse AT curlingjm productionofplasmaproteinsfortherapeuticuse |